Delayed
Canadian Securities Exchange
07:00:00 21/08/2020 pm IST
|
5-day change
|
1st Jan Change
|
0.4
CAD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: May |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7.753
|
2.218
|
11.72
|
11.72
|
11.72
|
Enterprise Value (EV)
1 |
7.748
|
1.76
|
11.49
|
11.76
|
11.81
|
P/E ratio
|
-1.09
x
|
-1.64
x
|
-12.1
x
|
-4.47
x
|
-41.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-1,59,22,564
x
|
13,20,30,148
x
|
-41,18,139
x
|
55,48,210
x
|
19,19,84,247
x
|
FCF Yield
|
-0%
|
0%
|
-0%
|
0%
|
0%
|
Price to Book
|
-20.2
x
|
-8.4
x
|
5.92
x
|
-18.5
x
|
-12.8
x
|
Nbr of stocks (in thousands)
|
1,938
|
6,721
|
29,308
|
29,308
|
29,308
|
Reference price
2 |
4.000
|
0.3300
|
0.4000
|
0.4000
|
0.4000
|
Announcement Date
|
04/12/19
|
28/09/20
|
30/09/21
|
29/09/22
|
28/09/23
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.2443
|
-2.756
|
-0.5149
|
-0.535
|
-0.3681
|
-0.2663
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.3528
|
-6.391
|
-0.3862
|
-0.8829
|
-2.62
|
-0.2797
|
Net income
1 |
-0.3528
|
-6.391
|
-0.3853
|
-0.8829
|
-2.62
|
-0.2797
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.7754
|
-3.667
|
-0.2016
|
-0.0331
|
-0.0894
|
-0.009543
|
Free Cash Flow
|
-
|
-0.4866
|
0.0133
|
-2.789
|
2.119
|
0.0615
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/08/18
|
04/12/19
|
28/09/20
|
30/09/21
|
29/09/22
|
28/09/23
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
0.03
|
0.09
|
Net Cash position
1 |
0.35
|
0.01
|
0.46
|
0.24
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.49
|
0.01
|
-2.79
|
2.12
|
0.06
|
ROE (net income / shareholders' equity)
|
-
|
-1,600%
|
119%
|
-103%
|
-390%
|
36.1%
|
ROA (Net income/ Total Assets)
|
-
|
-253%
|
-95.8%
|
-22.2%
|
-18.9%
|
-2,480%
|
Assets
1 |
-
|
2.523
|
0.4021
|
3.979
|
13.88
|
0.0113
|
Book Value Per Share
2 |
1.150
|
-0.2000
|
-0.0400
|
0.0700
|
-0.0200
|
-0.0300
|
Cash Flow per Share
2 |
0.3400
|
0
|
0.0700
|
0.0100
|
0
|
0
|
Capex
|
-
|
0.01
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/08/18
|
04/12/19
|
28/09/20
|
30/09/21
|
29/09/22
|
28/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 8.68M | | +41.06% | 6.19B | | -15.95% | 4.48B | | +6.36% | 3.29B | | -11.34% | 3.12B | | -3.12% | 2.5B | | +45.41% | 1.94B | | -7.74% | 1.68B | | -0.67% | 1.64B | | -11.32% | 1.56B |
Alternative Medicine
|